Paul Lizzul

2022

In 2022, Paul Lizzul earned a total compensation of $3.8M as Chief Medical Officer at ANAPTYSBIO.

Compensation breakdown

Non-Equity Incentive Plan$174,544
Option Awards$2,872,730
Salary$471,740
Stock Awards$283,440
Other$10,074
Total$3,812,528

Lizzul received $2.9M in option awards, accounting for 75% of the total pay in 2022.

Lizzul also received $174.5K in non-equity incentive plan, $471.7K in salary, $283.4K in stock awards and $10.1K in other compensation.

Rankings

In 2022, Paul Lizzul's compensation ranked 923rd out of 5,751 executives tracked by ExecPay. In other words, Lizzul earned more than 84.0% of executives.

ClassificationRankingPercentile
All
923
out of 5,751
84th
Division
Manufacturing
424
out of 3,131
87th
Major group
Chemicals And Allied Products
153
out of 1,419
89th
Industry group
Drugs
139
out of 1,320
90th
Industry
Pharmaceutical Preparations
103
out of 966
89th
Source: SEC filing on April 24, 2024.

Lizzul's colleagues

We found two more compensation records of executives who worked with Paul Lizzul at ANAPTYSBIO in 2022.

2022

Daniel Faga

ANAPTYSBIO

Chief Executive Officer

2022

Eric Loumeau

ANAPTYSBIO

Chief Legal Officer

News

In-depth

You may also like